HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark C Gebhardt Selected Research

Mark C Gebhardt Research Topics

Disease

27Neoplasms (Cancer)
01/2023 - 02/2002
13Sarcoma (Soft Tissue Sarcoma)
09/2023 - 02/2003
12Osteosarcoma (Osteogenic Sarcoma)
01/2017 - 01/2002
9Ewing Sarcoma (Sarcoma, Ewing)
01/2023 - 02/2003
8Neoplasm Metastasis (Metastasis)
01/2023 - 07/2002
5Infections
01/2023 - 01/2002
5Primitive Neuroectodermal Tumors (PNET)
12/2007 - 02/2003
4Necrosis
01/2023 - 06/2008
3Margins of Excision
01/2023 - 10/2003
3Spontaneous Fractures (Pathological Fracture)
10/2008 - 01/2002
2Pain (Aches)
09/2021 - 10/2008
2Left Ventricular Dysfunction
10/2016 - 01/2016
2Cardiotoxicity
01/2016 - 07/2004
2Giant Cell Tumors (Giant Cell Tumor)
09/2004 - 07/2002
1Infarction (Infarctions)
10/2016
1Cysts
10/2008
1Bone Cysts (Bone Cyst)
10/2008
1Phantom Limb (Phantom Limbs)
06/2008
1Adamantinoma
03/2008
1Second Primary Neoplasms (Neoplasms, Second)
12/2007
1Fibroma (Fibromatosis)
02/2007
1Vomiting
02/2007
1Aggressive Fibromatosis (Desmoid)
02/2007
1Anemia
02/2007
1Nausea
02/2007
1Alveolar Soft Part Sarcoma
09/2005
1Dermatofibrosarcoma
05/2005
1Sepsis (Septicemia)
07/2004
1Heart Arrest (Cardiac Arrest)
10/2003
1Cellulitis
10/2003
1Disease Progression
04/2003
1Fibrosarcoma
12/2002
1Aneuploidy (Aneuploid)
02/2002
1Chordoma
02/2002

Drug/Important Bio-Agent (IBA)

8IfosfamideFDA LinkGeneric
10/2016 - 01/2002
6Doxorubicin (Adriamycin)FDA LinkGeneric
10/2016 - 07/2004
6Etoposide (VP 16)FDA LinkGeneric
10/2016 - 01/2002
4Methotrexate (Mexate)FDA LinkGeneric
10/2016 - 02/2007
3MicroRNAs (MicroRNA)IBA
01/2017 - 07/2012
3Cisplatin (Platino)FDA LinkGeneric
10/2016 - 02/2008
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2007 - 07/2004
2Dihydrotachysterol (AT 10)IBA
01/2023 - 05/2004
2ParaffinIBA
01/2013 - 07/2012
2Vincristine (Oncovin)FDA LinkGeneric
08/2006 - 07/2004
2Dactinomycin (Actinomycin)FDA LinkGeneric
08/2006 - 07/2004
1Untranslated RNA (Noncoding RNA)IBA
01/2017
1microbial alkaline proteinase inhibitor (MAPI)IBA
01/2016
1AnthracyclinesIBA
01/2016
1Dexrazoxane (Zinecard)FDA LinkGeneric
01/2016
1Formaldehyde (Formol)FDA Link
01/2013
1Biomarkers (Surrogate Marker)IBA
01/2013
1Messenger RNA (mRNA)IBA
01/2013
1EWS-FLI fusion proteinIBA
10/2012
1Peptides (Polypeptides)IBA
10/2012
1GadoliniumIBA
07/2010
1SteroidsIBA
10/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2008
1Keratins (Keratin)IBA
03/2008
1Vinblastine (Vinblastine Sulfate)FDA Link
02/2007
1Transaminases (Aminotransferases)IBA
02/2007
1osteoadherinIBA
05/2005
1Drug CombinationsIBA
02/2003
1DNA (Deoxyribonucleic Acid)IBA
02/2002

Therapy/Procedure

23Drug Therapy (Chemotherapy)
01/2023 - 01/2002
8Therapeutics
10/2016 - 01/2002
7Radiotherapy
01/2023 - 07/2003
6Neoadjuvant Therapy
01/2023 - 01/2002
5Limb Salvage
09/2023 - 01/2002
4Surgical Amputation (Amputations)
01/2023 - 01/2002
3Aftercare (After-Treatment)
01/2023 - 09/2005
3Induction Chemotherapy
10/2016 - 01/2002
3Curettage
10/2008 - 08/2007
2Prostheses and Implants (Prosthesis)
06/2008 - 03/2004
1Self-Help Devices (Assistive Technology)
09/2021
1Operative Surgical Procedures
06/2016
1Bone Transplantation (Bone Grafting)
10/2008
1Retreatment
10/2008
1Regimen B
07/2004
1Anesthesia
10/2003
1Adjuvant Chemotherapy
04/2003
1Replacement Arthroplasty
07/2002
1Arthrodesis
07/2002
1Reoperation
04/2002